SURETACS Trademark

Trademark Overview


On Friday, April 29, 2022, a trademark application was filed for SURETACS with the United States Patent and Trademark Office. The USPTO has given the SURETACS trademark a serial number of 79342846. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by Laigo Bio B.V.. The SURETACS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, medicinal preparations for the treatment of cancer, inflammation, neurodegeneration and immune disorders; pharmaceutical preparations for the treatment and the prevention of diseases and disorders, namely, anti-cancer, anti-inflammation, anti-neurodegeneration and immunological preparations; colostral antibodies for medical purposes

Scientific research; development of pharmaceutical preparations and medicines; medical and pharmacological research services; research, testing and inspection of pharmaceuticals; medical and pharmacological research and development services in the field of antibodies; creation and maintenance of websites for others in the field of medical research and pharmaceuticals
suretacs

General Information


Serial Number79342846
Word MarkSURETACS
Filing DateFriday, April 29, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220502
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, medicinal preparations for the treatment of cancer, inflammation, neurodegeneration and immune disorders; pharmaceutical preparations for the treatment and the prevention of diseases and disorders, namely, anti-cancer, anti-inflammation, anti-neurodegeneration and immunological preparations; colostral antibodies for medical purposes
Goods and ServicesScientific research; development of pharmaceutical preparations and medicines; medical and pharmacological research services; research, testing and inspection of pharmaceuticals; medical and pharmacological research and development services in the field of antibodies; creation and maintenance of websites for others in the field of medical research and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLaigo Bio B.V.
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameLaigo Bio B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameLaigo Bio B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 22, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 2, 2023REFUSAL PROCESSED BY IB
Thursday, April 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 6, 2023REFUSAL PROCESSED BY MPU
Saturday, February 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 17, 2023NON-FINAL ACTION WRITTEN
Friday, February 17, 2023ASSIGNED TO EXAMINER
Tuesday, June 21, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB